Cytokine Release Syndrome in COVID-19-induced Pneumonia
1 clinical trials · Condition
◉ Watch Cytokine Release Syndrome in COVID-19-induced Pneumonia
| Record | Firm | Date |
|---|---|---|
| Canakinumab MAP in COVID-19 Pneumonia With CRS (NCT04476706) | Novartis Pharmaceuticals |
Track Cytokine Release Syndrome in COVID-19-induced Pneumonia automatically
Every clearance here is in the API, with alerts when new ones post.